@article{02f63526a1be4fd2b38d9e006408ea16,
title = "Potentials and current limitations of brain stimulation therapies to accelerate antidepressant response",
author = "Shinichiro Nakajima and Takefumi Suzuki and Koichiro Watanabe and Haruo Kashima and Hiroyuki Uchida",
note = "Funding Information: Dr. Watanabe has served on the advisory board of Dainippon Sumitomo Pharma, Eli Lilly, Janssen, Otsuka and Schering–Plough and received speaker's honoraria from Asahi Kasei, Astellas, Dainippon Sumitomo, Eli Lilly, GlaxoSmithKline, Janssen, Otsuka, and Pfizer within the past 5 years. Dr. Uchida has received grants from Pfizer and speaker's honoraria or manuscript fees from Dainippon Sumitomo Pharma, GlaxoSmithKline, Jannsen Pharmaceutical, and Otsuka within the past 5 years. Other authors have no financial or other relationship relevant to the subject of this manuscript.",
year = "2010",
month = mar,
doi = "10.1016/j.pnpbp.2010.01.012",
language = "English",
volume = "34",
pages = "439--440",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "2",
}